D-Amino Acid Oxidase Inhibition: A New Glutamate Twist for Clozapine Augmentation in Schizophrenia?

  • Paul J. Harrison
    Address correspondence to Paul J. Harrison, D.M., F.R.C.Psych., Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, United Kingdom.
    Department of Psychiatry, University of Oxford, and Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, United Kingdom
    Search for articles by this author
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Lin C.-H.
        • Lin C.-H.
        • Chang Y.-C.
        • Huang Y.-J.
        • Chen P.-W.
        • Yang H.-T.
        • Lane H.-Y.
        Sodium benzoate, a D-amino acid oxidase inhibitor, added to clozapine for the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial.
        Biol Psychiatry. 2018; 84: 422-432
        • Lane H.Y.
        • Lin C.H.
        • Green M.F.
        • Hellemann G.
        • Huang C.G.
        • Chen P.W.
        • et al.
        Add-on treatment of benzoate for schizophrenia: A randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
        JAMA Psychiatry. 2013; 70: 1267-1275
        • Verrall L.J.
        • Betts J.F.
        • Burnet P.W.J.
        • Harrison P.J.
        The neurobiology of D-amino acid oxidase (DAO) and its involvement in schizophrenia.
        Mol Psychiatry. 2010; 15: 122-137
        • Papouin T.
        • Ladapeche L.
        • Ruel J.
        • Saachi S.
        • Labasque M.
        • Hanini M.
        • et al.
        Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.
        Cell. 2012; 150: 633-646
        • Burnet P.W.J.
        • Eastwood S.L.
        • Bristow G.
        • Godlewska B.R.
        • Sikka P.
        • Walker M.
        • Harrison P.J.
        D-amino acid oxidase activity and expression are increased in schizophrenia.
        Mol Psychiatry. 2008; 13: 658-660
        • Verrall L.
        • Walker M.
        • Rawlins N.
        • Bunzel I.
        • Kew J.N.C.
        • Harrison P.J.
        • Burnet P.W.J.
        D-amino acid oxidase and serine racemase in human brain: Normal distribution and altered expression in schizophrenia.
        Eur J Neurosci. 2007; 26: 1657-1669
        • Betts J.F.
        • Schweimer J.V.
        • Burnham K.E.
        • Burnet P.W.J.
        • Sharp T.
        • Harrison P.J.
        D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine.
        Front Synaptic Neurosci. 2014; 6: 11
        • Saachi S.
        • Binelli G.
        • Pollegioni L.
        G72 primate-specific gene: A still enigmatic element in psychiatric disorders.
        Cell Mol Life Sci. 2016; 73: 2029-2039
        • Howley E.
        • Bestwick M.
        • Fradley R.
        • Harrison H.
        • Leveridge M.
        • Okada K.
        • et al.
        Assessment of the target engagement and D-serine biomarker profiles of the D-amino acid oxidase inhibitors sodium benzoate and PGM030756.
        Neurochem Int. 2017; 42 (3779–3288)
        • Piper J.D.
        • Piper P.W.
        Benzoate and sorbate salts: A systematic review of the potential hazards of these invaluable preservatives and the expanding spectrum of clinical uses for sodium benzoate.
        Compr Rev Food Sci Food Safety. 2017; 16: 868-880

      Linked Article